METHOD FOR ESTIMATING SENSITIVITY TO DRUG THERAPY FOR COLORECTAL CANCER
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Oct 16, 2015
filing date -
Oct 17, 2014
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present invention relates to a method for predicting responsiveness to cancer drug therapy for colorectal cancer. More particularly, the present invention relates to a method for predicting the responsiveness of a colorectal cancer patient to cancer drug therapy, the method comprising analyzing the level of DNA methylation in a specimen comprising a colorectal cancer tissue, colorectal cancer cells, or colorectal cancer cell-derived DNA of a subject, and then determining the responsiveness of the subject to cancer drug therapy based on the level of DNA methylation.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully